Comparing Detection Schemes for Adversarial Images against Deep Learning Models for Cancer Imaging.
Marina Z JoelArman AvestaDaniel X YangJian-Ge ZhouAntonio OmuroRoy S HerbstHarlan M KrumholzSanjay AnejaPublished in: Cancers (2023)
Deep learning (DL) models have demonstrated state-of-the-art performance in the classification of diagnostic imaging in oncology. However, DL models for medical images can be compromised by adversarial images, where pixel values of input images are manipulated to deceive the DL model. To address this limitation, our study investigates the detectability of adversarial images in oncology using multiple detection schemes. Experiments were conducted on thoracic computed tomography (CT) scans, mammography, and brain magnetic resonance imaging (MRI). For each dataset we trained a convolutional neural network to classify the presence or absence of malignancy. We trained five DL and machine learning (ML)-based detection models and tested their performance in detecting adversarial images. Adversarial images generated using projected gradient descent (PGD) with a perturbation size of 0.004 were detected by the ResNet detection model with an accuracy of 100% for CT, 100% for mammogram, and 90.0% for MRI. Overall, adversarial images were detected with high accuracy in settings where adversarial perturbation was above set thresholds. Adversarial detection should be considered alongside adversarial training as a defense technique to protect DL models for cancer imaging classification from the threat of adversarial images.
Keyphrases
- deep learning
- convolutional neural network
- machine learning
- computed tomography
- contrast enhanced
- magnetic resonance imaging
- artificial intelligence
- high resolution
- optical coherence tomography
- loop mediated isothermal amplification
- dual energy
- label free
- real time pcr
- positron emission tomography
- papillary thyroid
- image quality
- big data
- healthcare
- climate change
- magnetic resonance
- squamous cell
- brain injury
- young adults
- multiple sclerosis
- palliative care
- mass spectrometry
- subarachnoid hemorrhage
- body composition
- fluorescence imaging